Cardiff Oncology (CRDF) Stock Chart & Stock Price History → I’m officially sounding the alarm. (From Altimetry) (Ad) Free CRDF Stock Alerts $4.38 +0.01 (+0.23%) (As of 09:01 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cardiff Oncology Stock Price Performance5 Day Performance-21.93%1 Month Performance-10.06%3 Month Performance+190.07%6 Month Performance+305.56%Year-To-Date Performance+195.95%1 Year Performance+192.00% Receive CRDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. CRDF Stock Chart for Friday, April, 19, 2024 CRDF Chart by TradingView Cardiff Oncology Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$4.50$4.37-2.89%$4.48$4.26827,721 shs$195.25 million04/17/2024$4.59$4.50-1.96%$4.86$4.32847,990 shs$201.06 million04/16/2024$5.28$4.59-13.07%$5.25$4.202.16 million shs$205.07 million04/15/2024$5.61$5.28-5.88%$5.66$5.24654,109 shs$235.91 million04/12/2024$5.67$5.61-1.06%$5.86$5.35824,997 shs$250.66 million04/11/2024$5.89$5.67-3.74%$5.96$5.57557,121 shs$253.34 million Get the Latest News and Ratings for CRDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$5.66$5.89+4.06%$5.98$5.30710,673 shs$263.17 million04/09/2024$5.88$5.66-3.74%$6.27$5.58943,656 shs$252.89 million04/08/2024$5.84$5.88+0.68%$6.25$5.56841,547 shs$262.72 million04/05/2024$5.67$5.84+3.00%$6.35$5.751.42 million shs$260.93 million04/04/2024$5.33$5.67+6.38%$6.38$5.461.88 million shs$253.34 million04/03/2024$5.37$5.33-0.74%$5.61$5.22749,044 shs$238.14 million04/02/2024$5.73$5.37-6.28%$5.61$5.23613,779 shs$239.93 million04/01/2024$5.34$5.73+7.30%$5.87$5.20876,769 shs$256.02 million03/29/2024$5.34$5.34$5.73$5.19864,484 shs$238.59 million03/28/2024$5.75$5.34-7.13%$5.73$5.19864,279 shs$238.59 million03/27/2024$5.39$5.75+6.68%$5.76$5.311.77 million shs$256.91 million03/26/2024$5.91$5.39-8.80%$6.05$5.341.45 million shs$240.83 million03/25/2024$5.85$5.91+1.03%$6.42$5.621.97 million shs$264.06 million03/22/2024$5.14$5.85+13.81%$6.11$5.012.74 million shs$261.36 million03/21/2024$4.96$5.14+3.63%$5.30$4.78795,106 shs$229.66 million03/20/2024$4.87$4.96+1.85%$5.23$4.70938,749 shs$221.61 million03/19/2024$5.17$4.87-5.80%$5.15$4.71705,412 shs$217.59 million03/18/2024$5.03$5.17+2.78%$5.40$4.211.83 million shs$231.00 million03/15/2024$5.40$5.03-6.85%$5.63$4.612.01 million shs$224.74 million03/14/2024$5.40$5.40$6.06$5.102.97 million shs$241.27 million03/13/2024$4.48$5.40+20.54%$5.85$4.503.97 million shs$241.27 million03/12/2024$4.04$4.48+10.89%$4.59$4.001.46 million shs$200.15 million03/11/2024$4.14$4.04-2.42%$4.36$3.782.16 million shs$180.51 million03/08/2024$3.51$4.14+17.95%$4.18$3.551.81 million shs$184.96 million03/07/2024$3.89$3.51-9.77%$4.12$3.322.02 million shs$156.83 million03/06/2024$3.65$3.89+6.58%$4.11$3.582.70 million shs$173.81 million03/05/2024$3.49$3.65+4.58%$3.84$3.182.84 million shs$163.08 million03/04/2024$2.91$3.49+19.93%$3.85$2.9612.85 million shs$155.93 million03/01/2024$1.77$2.91+64.87%$3.07$2.0045.05 million shs$130.02 million02/29/2024$1.82$1.77-3.02%$1.91$1.741.89 million shs$78.86 million02/28/2024$1.78$1.82+2.25%$1.93$1.78289,035 shs$81.32 million02/27/2024$1.71$1.78+4.09%$1.84$1.72165,602 shs$79.53 million02/26/2024$1.67$1.71+2.40%$1.76$1.66132,385 shs$76.40 million02/23/2024$1.68$1.67-0.60%$1.71$1.6569,082 shs$74.62 millionI’m officially sounding the alarm. (Ad)AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.Just click here to watch my full uncensored interview.02/22/2024$1.68$1.68$1.73$1.6563,904 shs$75.06 million02/21/2024$1.70$1.68-1.18%$1.73$1.6686,137 shs$75.06 million02/20/2024$1.73$1.70-1.73%$1.76$1.6962,100 shs$75.96 million02/19/2024$1.73$1.73$1.78$1.7170,100 shs$77.30 million02/16/2024$1.75$1.73-1.14%$1.78$1.7169,006 shs$77.30 million02/15/2024$1.74$1.75+0.57%$1.82$1.70214,255 shs$78.19 million02/14/2024$1.66$1.74+4.82%$1.77$1.66114,956 shs$77.74 million02/13/2024$1.82$1.66-8.79%$1.78$1.63230,101 shs$74.17 million02/12/2024$1.81$1.82+0.55%$1.85$1.77119,423 shs$81.32 million02/09/2024$1.80$1.81+0.56%$1.89$1.76129,980 shs$80.87 million02/08/2024$1.87$1.80-3.74%$1.90$1.78168,404 shs$80.42 million02/07/2024$1.81$1.87+3.31%$1.90$1.73340,646 shs$83.55 million02/06/2024$1.49$1.81+21.48%$1.88$1.471.05 million shs$80.87 million02/05/2024$1.59$1.49-6.29%$1.62$1.44338,243 shs$66.57 million02/02/2024$1.62$1.59-1.85%$1.66$1.5396,597 shs$71.04 million02/01/2024$1.56$1.62+3.85%$1.71$1.56341,743 shs$72.38 million01/31/2024$1.54$1.56+1.30%$1.62$1.55101,026 shs$69.70 million01/30/2024$1.58$1.54-2.53%$1.58$1.5347,248 shs$68.81 million01/29/2024$1.49$1.58+6.04%$1.58$1.4967,770 shs$70.59 million01/26/2024$1.49$1.49$1.51$1.4658,709 shs$66.57 million01/25/2024$1.52$1.49-1.65%$1.56$1.4761,959 shs$66.57 million01/24/2024$1.53$1.52-0.98%$1.57$1.4792,775 shs$67.69 million01/23/2024$1.52$1.53+0.66%$1.57$1.5150,383 shs$68.36 million01/22/2024$1.51$1.52+0.66%$1.56$1.5156,940 shs$67.91 million01/19/2024$1.47$1.51+2.72%$1.61$1.4677,208 shs$67.47 million01/18/2024$1.47$1.47$1.52$1.4594,371 shs$65.68 million Related Companies: ADVM Stock Chart IPSC Stock Chart OPT Stock Chart KOD Stock Chart STRO Stock Chart ABOS Stock Chart CMPX Stock Chart ELEV Stock Chart BDTX Stock Chart SCLX Stock Chart Receive CRDF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRDF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiff Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.